$0.898000
At close: Nov 20, 9:24 AM EDT
$0.910000
0.011.34%
After Hours: 9:24 AM EDT
Comments
Loading...
Shuttle Pharmaceuticals (SHPH) Forecast
NewsEarningsShuttle Pharmaceuticals (SHPH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestShuttle Pharmaceuticals (NASDAQ:SHPH) Stock Quotes, Forecast and News Summary
Shuttle Pharmaceuticals Stock (NASDAQ: SHPH) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Shuttle Pharmaceuticals (SHPH) stock?
You can purchase shares of Shuttle Pharmaceuticals (NASDAQ:SHPH) through any online brokerage.
Who are Shuttle Pharmaceuticals (SHPH) competitors?
Other companies in Shuttle Pharmaceuticals’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Palisade Bio (NASDAQ:PALI) and NuCana (NASDAQ:NCNA).
What is the forecast, or price target, for Shuttle Pharmaceuticals (SHPH) stock?
There is no analysis for Shuttle Pharmaceuticals to provide a consensus price target.
What is the current price for Shuttle Pharmaceuticals (SHPH)?
The stock price for Shuttle Pharmaceuticals (NASDAQ: SHPH) is $0.91 last updated November 20, 2024 at 9:24 AM EST.
Does Shuttle Pharmaceuticals (SHPH) pay a dividend?
There are no upcoming dividends for Shuttle Pharmaceuticals.
When is Shuttle Pharmaceuticals (NASDAQ:SHPH) reporting earnings?
Shuttle Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Shuttle Pharmaceuticals (SHPH) going to split?
There is no upcoming split for Shuttle Pharmaceuticals.
What sector and industry does Shuttle Pharmaceuticals (SHPH) operate in?
Shuttle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.